A novel series of coumarin-4-carboxylate ligands (2a-2l), their Ag(I) complexes (3a-3l) together with a number of their phenanthroline adducts (4d, 4f and 4g) have been synthesised and characterised. The ligands were prepared by either acid or base hydrolysis of their corresponding esters or by demethylation of a methylated acid derivative. The esters (1a-1i) were synthesised by an aromatic electrophilic substitution reaction between the conjugate base of substituted phenols and a vinyltriphenylphosphonium salt. The novel series of Ag(I) carboxylate complexes were prepared by reaction of silver nitrate with the coumarin ligands in aqueous/alcohol solution. The Ag(I) phenanthroline adducts were prepared by reaction of the Ag(I) complex with 1,10-phenanthroline in aqueous/alcohol solution. A selection of complexes were screened for their in vitro antibacterial activity against Pseudomonas aeruginosa grown planktonically or as a biofilm as well as a number of other clinically important strains, Escherichia coli, MRSA and Staphylococcus aureus. The activity against the P. aeruginosa biofilm was found to be significantly greater than against the planktonic bacteria.
Introduction
The Centres for Disease Control and Prevention in America have estimated that 2 million patients suffer from hospital-acquired infections (HAIs) every year and from that number there are approximately 100,000 deaths [1] . Hospital acquired infections result in significant levels of illness, death and financial cost to global healthcare systems. Many HAIs are a side effect of medical treatments such as surgery and the use of implanted medical devices including prosthetic implants and central venous and urinary catheters [2] . For the most part of the last decade, Methicillin-resistant Staphylococcus aureus (MRSA) was the leading cause of HAIs in Ireland [3] . However, another bacterium, Pseudomonas aeruginosa, is of increasing concern worldwide with for example 200,000 HAIs directly related to that organism annually in the USA alone [4] . Bacteria such P. aeruginosa, Staphylococci and Escherichia coli that can exist in biofilms exhibit extreme resistance compared to planktonic or free moving bacteria as they are protected from the host's immune cells and from the action of antimicrobial agents. It is reported that to kill bacteria in a biofilm requires 1000 times the antibiotic dose necessary to kill a planktonic population of cells [1] . Up to 65-80% of human infections are caused by biofilms and these are often the underlying reason why treatment with antibiotics can fail [5] . The ever-increasing problem of microbial resistance means that there is a need to develop effective strategies to prevent and control HAIs. One such approach is to synthesise new antimicrobial agents that effectively inhibit the growth of microorganisms and which can be used as additives in efficient surface technologies such as coatings and paints and in topical healthcare products. The use of antimicrobial coatings in the clinical environment can aid in reducing the risk of cross contamination and transmission of microbes and also help overcome antimicrobial drug resistance.
There is a renewed interest in the use of silver metal and silver(I) salts and compounds as antimicrobial agents. The antimicrobial activity of silver has long been known but the introduction of penicillin in the 1940s meant that antibiotics became the standard treatment for infections and silver was no longer used. In the 1960s silver nitrate was used to treat burn victims which led to the production of silver sulfadiazine cream [6, 7] . Silver in its ionic form, Ag(I), is active against a broad range of microbes even at low concentrations. Silver displays broad spectrum activity in which it attacks multiple sites [8, 9] . Studies have shown that the most important mechanism of action of Ag(I) is based on its surface binding and damage to the membrane function [10] . More recently there are a number of products (topical creams, wound dressings, sutures, catheters etc.) on the market that incorporate a form of silver to produce an antimicrobial effect. Topical treatments in the form of hydrogels such as Silvasorb [11] and Silver Shield [12] and wound dressings such as those from Acticoat™ [13] , Aquacel Ò (acticoat) and Silvercel Ò are alternatives to antibiotic treatment. A number of silver antimicrobial additives manufactured for use in many applications include AgIon from AgIon [14] , and Biomaster from Addmaster [15] . Whilst there are a number of biocidal silver products currently available on the market, there is still a need to develop more efficient cost effective silver-based products which offer long-term antimicrobial activity. Using Ag(I) complexes which contain both an organic (ligand) and inorganic (metal) component as the biocidal additive represents a novel approach. The use of Ag(I) complexes as biocidal additives in hygienic coatings has been demonstrated by our previous work in which Ag(I) complexes of coumarin-3-carboxylates were successfully incorporated into sol-gel derived coatings. The thin-film coatings were found to be effective against MRSA and Enterobacter cloacae WT6 strains at low silver loadings (0.3% w/w) and were less toxic than coatings containing silver nitrate and showed potential for use in the clinical environment [16] .
In this present work we have prepared a series of novel 4-coumarin carboxylate Ag(I) complexes. Coumarin and its derivatives have shown a diverse array of biological activities including antimicrobial [17] , chemotherapeutic [18, 19] , anticoagulant [20] and antiinflammatory [21] . A number of both naturally occurring and synthetic coumarins including aminocoumarins [22, 23] , hydroxycoumarins [24, 25] , pyranocoumarins [26] , and furanocoumarins [27] have been reported to have significant antimicrobial activity against a wide range of microbes. Following on from our previous work on a series of Ag(I) complexes of coumarin-3-carboxylates, which have proven antimicrobial activity and potential as effective biocides in hygienic coatings, a novel series of Ag(I) complexes of coumarin-4-carboxylates has been synthesised and screened for their antibacterial activity. In addition, three Ag(I) complexes containing coumarin carboxylates and phenanthroline (phen) ligands were also isolated and their antimicrobial activity investigated.
Experimental

Materials/general methods
All chemicals purchased from Sigma-Aldrich were reagent grade and used without purification. Infrared spectra were recorded in the region of 4000-400 cm
À1
, on a Nicolet Impact 410 Fourier-Transform Infrared spectrophotometer using Omnic software. NMR spectra were obtained from both JOEL and Bruker spectrometers in d 6 All of the esters 1a-1i (Fig. S1 in Supplementary data and Table 1) were synthesised using the following general procedure. The appropriate phenol (40 mmol) and triphenylphosphine (7.8 g, 30 mmol) were dissolved with stirring in dichloromethane (80 ml). To this a solution of dimethyl acetylenedicarboxylate (5 ml, 5.68 g, 40 mmol) in dichloromethane (20 ml) was added dropwise over 10 min at À5°C. The reaction mixture was allowed to warm to room temperature and then refluxed for 100 h. The solvent was removed by reduced pressure to leave a fine microcrystalline mass which was recrystallised from hot ethanol. The resulting crystals were isolated by filtration, washed with ethanol and air-dried. The esters were used as the precursors for the synthesis of the carboxylate ligands. All esters were fully characterised by 1 H, 13 C NMR and IR spectroscopies, as well as by elemental analyses, melting point and TLC analysis (given as Supplementary data in Tables S1-S3 ).
Synthesis of substituted coumarin acids 2a, 2b and 2d-2i
The coumarin acids 2a, 2b and 2d-2i were synthesised using the following general procedure. The appropriate ester (1 mmol), sodium hydroxide solution (2 M, 10 ml) and ethanol (95%, 5 ml) were heated under reflux for 2 h. After cooling, concentrated hydrochloric acid (37%) was added drop wise to the solution until a precipitate formed. The resulting solid was isolated by filtration, washed with water and dried in a vacuum oven until a constant mass was obtained.
Synthesis of 8-methoxycoumarin-4-carboxylic acid [8-OCH 3 CAH] (2c)
Methyl-8-methoxy-coumarin-4-carboxylate (0.7 g, 3 mmol), 20 ml of hot water and concentrated hydrochloric acid (37%, 2 ml) were added to a round bottom flask. The coumarin did not dissolve and the resulting suspension was refluxed with stirring for 11 h. The resulting yellow solid was isolated by filtration, washed first with water (20 ml) and then with ethanol (20 ml) and dried in a vacuum oven until a constant mass was obtained. 6-methoxycoumarin-4-carboxylic acid (2a) (0.44 g, 2 mmol) and pyridine hydrochloride (3 g, 26 mmol) were irradiated at 200°C for 2 min in a microwave synthesiser. The vessel was cooled to room temperature and irradiated once more for a further 2 min. To this, ice-cold water (10 ml) was added, followed by concentrated hydrochloric acid (1 M, 10 ml). The reaction mixture was then extracted with ethyl acetate (40 ml Â 2) using a separating funnel. The resulting organic layer was washed with water (20 ml Â 2), dried over sodium sulphate and the solvent was removed by reduced pressure. A dark yellow solid (2j) was obtained. 
Synthesis of substituted coumarin-4-carboxylatosilver(I) complexes (3a-3l)
Syntheses of the Ag(I) complexes were conducted in the absence of light and all complexes were stored in the dark. The Ag(I) complexes were prepared by the following general method: coumarin acid (1 mmol) was heated with stirring in a aqueous solution of sodium hydroxide (0.04 g, 1 mmol in 10 ml of water). After cooling the resultant suspension to room temperature, silver(I) nitrate solution (0.170 g, 1 mmol in water (10 ml)) was added to it, drop wise over 10 min. The suspension was then stirred for 1 h and the resulting precipitate was isolated by filtration, washed with hot ethanol (20 ml) and then with cold water (20 ml). The solid was then air-dried in the dark. Analytical data for the Ag(I) complexes is given in Tables 6-9. 2.4. Synthesis of 6-chlorocoumarin-4-carboxylatobis(phenanthro line)silver(I)Á3.5H 2 O (4d), 8-chloro-6-methoxycoumarin-4-carboxy lato(phenanthroline)silver(I) (4f) and 6-chloro-8-methoxycoumarin-4-carboxylatebis(phenanthroline)silver(I)Á3.5H 2 O (4g)
The Ag(I) phenanthroline adducts (4d, 4f and 4g) were prepared by the following general method: coumarin acid (0.5 mmol) and sodium hydroxide solution (0.02 g, 0.5 mmol in water (10 ml)) were stirred for 30 min. A silver nitrate solution (0.085 g, 0.5 mmol in water (10 ml)) was added drop wise to the coumarin solution, the resultant yellow suspension was stirred for 1 h. 1,10-Phenanthroline (0.180 g, 1 mmol) dissolved in ethanol (10 ml) was then added and the reaction mixture was stirred for a further 2 h. A yellow solid was isolated by filtration, washed with water (30 ml), methanol (20 ml) and allowed to air-dry. Analytical data for the complexes is given in Tables 6-9.
Antimicrobial studies
The ligands (2a-l), Ag(I) complexes (3a-l), phenanthroline adducts (4d, 4f and 4g) and commercially available drugs gentamycin and vancomycin were screened for their antimicrobial activity. E. coli (NCIMB 9485), S. aureus (NCIMB 12702) were obtained from the National Collection of Industrial, Marine and Food. MRSA (ATCC4300) and P. aeruginosa strains (PA01 and ATCC 27853) were obtained from the American Type Culture Collection. E. coli and P. aeruginosa were cultured in Luria Bertani (LB) broth (Sigma) while S. aureus was cultured in Tryptone Soy Broth (TSB, LabM, UK). MRSA was cultured in nutrient broth. Bacteria were stored in broth with 20% glycerol at À80°C, and passaged twice on agar plate (LB agar, TSA or nutrient agar respectively) before being used in an experiment. Minimum inhibitory concentrations (MIC) were determined by broth microdilution. Stock solutions of each compound to be tested were prepared in DMSO and serially diluted in triplicate using broth (100 ll/well) at a concentration range of 0.195-200 lM on microtitre plates, after which the final concentration of DMSO in the cell suspension was not greater than 1%. Overnight cultures (10 ml) of bacterial strains were inoculated in broth Table 2 Analytical data for the coumarin carboxylate ligands (2a-l). (100 ml) and incubated at 37°C with agitation, optical density at 600 nm (OD 600 ) was measured and strains were then diluted to 1 Â 10 6 CFU/ml and seeded at 100 ll/well in microtitre well plates.
Bacteria were also treated with a solvent control (0.5% DMSO) in control wells. Following 24 h incubation the absorbance was read in a microtitre plate reader [28] . Each compound was screened at each concentration at least in triplicate and three independent experiments were carried out. 
The MIC 90 values were determined as the concentration of test compound which inhibited 90% visible growth in 24 h.
Biofilm assay
Strains were cultured in Cation adjusted Mueller Hinton broth (CAMHB) overnight and inoculated in fresh CAMHB to reach an OD600 of 0.6. Bacterial biofilms were formed on pegs of a modified polystyrene lid by inoculating 100 ll of bacterial suspension (10 6 CFU/ml) to each well of a polystyrene plate and incubated for 20 h [29] . Peg lids were rinsed three times in sterile water and placed into 96 well plates containing a range of test dilutions in 100 ll CAMHB and incubated for 18 h. The peg lids were placed 0.5% crystal violet solution for 15 min, rinsed and dried for several hours. The pegs were then incubated in 95% ethanol with 0.05% Triton X 100 for 15 min and absorbance measured at 590 nm. The BIC 90 values, biofilm inhibitory concentration, were determined as the minimal concentration of compound needed to reduce biofilm formation by 90% after 18 h treatment.
Results and discussion
Synthesis and characterisation of the ligands
The carboxylate ligands were synthesised by first preparing their corresponding esters (1a-i) via an aromatic electrophilic substitution reaction between the conjugated base of substituted phenols and a vinyl triphenylphosphonium salt [30] . This reaction which involved refluxing the appropriate phenol with triphenylphosphine and dimethylacetylene dicarboxylate in dichloromethane for 100 h yielded the starting esters. The products were isolated by recrystallisation from ethanol and characterised by standard techniques. The acid derivatives were then synthesised by either acid or base hydrolysis of the corresponding ester or a demethylation reaction (Scheme 1). The acid derivative [8-OCH 3-CAH] (2c) was synthesised by refluxing the ester in water and 10% hydrochloric acid solution with an average reaction time of 11 h. Ester 1c was not soluble in the acid/water mixture and remained as a suspension; the suspended product was then isolated by filtration. The acid derivatives 2a, 2b and 2d-i could also be synthesised by this method however better yields were obtained by base hydrolysis. The acid 2c could also be synthesised by base hydrolysis but gave a higher yield when made using acid hydrolysis. Synthesis of the hydroxy substituted acid derivatives 2j-l was carried out by demethylation reaction of the corresponding methoxy substituted acids Scheme 2. Demethylation was achieved by a microwave-assisted reaction using pyridine hydrochloride followed by quenching with HCl and ice water; products were extracted using ethyl acetate [31] . Physical data and empirical formulae are presented in Table 2 . All of the ligands had good solubility in a range of organic solvents.
IR spectral data for the ligands is given in Table 3 . The formation of the coumarin acid derivatives was confirmed by the appearance of the characteristic acid bands, m C@O and m OH . There were two m C@O bands corresponding to the m C@O (acid) and the m C@O (lactone) and these were observed at between 1721-1677 and 1720-1737 cm À1 respectively. In a previous study on coumarin-3-carboxylate the lower frequency band was assigned to the lactone carbonyl though in this molecule intramolecular hydrogen bonding between the lactone carbonyl and hydrogen of the acid was thought to lower the frequency of the lactone carbonyl [32] . In the coumarin-4-car- Tables 4 and 5 respectively. The most characteristic signal in the 1 H NMR spectra of carboxylic acids is that of the OH group though not surprisingly in d 6 -DMSO it was not always observed (d OH varied from 14-9.82 ppm). A comparison of the 1 H NMR spectra of the acids with those of the corresponding esters shows the loss of the -CH 3 of the methyl signal at approximately 3.9 ppm confirming hydrolysis of the ester. The 13 C NMR signals of the coumarin acid ligands were assigned with the help of DEPT, HSQC and HMBC 2D experiments. The loss of the signal for the methyl ester carbon was observed in all of the spectra of the acids indicating that hydrolysis was complete.
Synthesis and characterisation of the complexes
The silver(I) complexes of the coumarin acids were formed by reaction with silver nitrate in aqueous solution in a 1:1 M ratio (Scheme 3). The acids were first deprotonated using NaOH prior to addition of silver nitrate. All Ag(I) complexes were isolated as insoluble precipitates from the reaction media and when dried and stored in the dark they appeared to be air and moisture stable. The complexes were soluble in DMSO only. Elemental analyses of the complexes 3a-l, were in agreement with the proposed 1:1 ligand:silver ratio (Table 6 ). Only the phen-containing complexes of ligands 2d, 2f and 2g were synthesised in acceptable purity. Previous studies have shown that inclusion of phen ligands in the coordination sphere of the cation not only improves solubility but has significantly improved bioactivity towards a number of clinically relevant species [34] . 4d, 4f and 4g were synthesised by firstly preparing the corresponding Ag(I) complex (3d, 3f and 3g) and leaving the product in the reaction solution. A solution of 1,10-phen in ethanol was then added to this solution in a molar ratio of 1:1:2 ligand:metal:phen. The phen complexes were soluble in DMSO (hot) only. Elemental analyses indicated a metal to ligand ratio of 1:1:2 for 4d and 4g with 3.5 water molecules in the formulation. A ratio of 1:1:1 ligand:metal:phen was observed for 4f (Table 6 ). All attempts at recrystallisation of the complexes isolated failed. Complex stability in DMSO solution was confirmed via measurement of 1 H NMR spectra of d 6 -DMSO samples of complexes stored over a period of months in the dark. No appreciable differences in the spectra were noted in this time.
IR spectra
The previously prepared complexes of coumarin-3-carboxylates allowed the identification of complexes, which whilst showing good antimicrobial activity, were polymeric in nature and had poor solubility in common organic solvents. We thought that might be related to the proximity of the carboxylate and lactone carbonyls which allowed for the formation of chelate complexes. Shifts of between 10 and 40 cm À1 in the lactone carbonyl seemed to confirm this coordination. Use of the 4-positon on the lactone ring for the carboxylate groups does not allow for the same type of coordination here and it was thought coordination to the carboxylate group alone would be favoured over bonding at the lactone carbonyl. On examination of the IR spectra of the complexes, in comparison to those of the ligands, the most significant observation was the disappearance of the acid carbonyl band and the appearance of the asymmetric (m asym (OCO)) and symmetric (m sym (OCO)) stretching frequencies. The m asym (OCO) and m sym (OCO) stretching frequencies and the Dm (OCO) values for the Ag(I) complexes are given in Table 7 . The complexes (3a-l) had Dm (OCO) values >200 cm À1 indicating unidentate carboxylate coordination to the Ag(I) centre [35] and are consistent with those previously reported for Ag(I) complexes of coumarin-3-carboxylates [36] . Interestingly, the m C@O (lactone) stretching vibration was shifted in all of the complexes by 11-56 cm À1 relative to the free ligand, upon formation of the Ag(I) complexes as was observed in the coumarin-3-carboxylates. Several reports have attributed such a shift to the participation of the coumarin lactone carbonyl in complexation to the metal ion [37] [38] [39] but it has also been reported for other coumarin derivatives where the lactone was not involved in complexation [40, 41] . In the latter instance the shift may be attributed to an increase in polarity of the lactone ring which can occur upon metal complexation. The insolubility of the complexes along with the IR data would suggest that they exist in the solid state as polymeric structures with extensive hydrogen bonding common to carboxylate structures as well as possible bonding of Ag(I) to both the deprotonated carboxylate oxygen and lactone carbonyl oxygen of
Scheme 1. General reaction scheme for the synthesis of the coumarin esters (1a-i) and the acids (2a-i).
neighbouring ligands. Changes observed in the weak absorption bands at 400-600 cm À1 in the spectra of the complexes were assigned to the M-O stretching vibrations [42, 43] . The IR spectra of the phen-containing complexes 4d, 4f and 4g were similar to each other and showed new absorption bands characteristic of chelating phenanthroline [44] , these occurring at ca. 1510, 841 and 726 cm À1 ( Table 7) . The Dm (OCO) values of the phen-complexes were also found to be >200 cm À1 indicating unidentate coordination of the coumarin carboxylate group to the Ag(I) ion in all cases. The presence of water molecules was confirmed by the broad band observed at $3400 cm À1 in each of the spectra. The changes observed in the weak absorption bands at 400-600 cm À1 in the IR spectra of the complexes is attributed to the M-O and M-N stretching frequencies.
NMR spectra
Peak assignments (see Fig. 1 for atom numbering) for the 1 H and 13 C NMR spectra of all the Ag(I) complexes in d 6 -DMSO solution are given in Tables 8 and 9 . In general, small shifts were observed for the aromatic protons upon complex formation but the greatest complexation induced shift (CIS) was observed for the vinyl proton H3 due to its proximity to the carboxylate group and this was shifted upfield by 0.45-0.56 ppm. The 13 C NMR spectra of the complexes revealed that the signals for the aromatic carbons (C5-C8) experienced a number of small shifts and the signal for the lactone carbonyl (C2) was mainly unaffected by complexation. The most significant shifts were observed for the carbons closest to the site of complexation, C3, C4 and C11. The signal for C4 experienced the greatest shift and was shifted downfield by 9.1-10.5 ppm. The carboxylate carbon, C11 was also shifted slightly downfield by 1-4 ppm and the vinyl carbon, C3 was found to be shifted slightly more upfield by 2-6.6 ppm in the spectra of the Ag(I) complexes. Similar patterns were also reported for the spectra of the Ag(I) complexes of the coumarin-3-carboxylates [35] . From the NMR data of the complexes it is likely that binding of the coumarin ligands to Ag(I) in solution phase is through unidentate coordination of the carboxylate group. Comparison of the 13 C NMR spectra of the free ligands and their Ag(I) complexes (Tables  5 and 9 ) identified that the carbons of the carboxylate (C11) and lactone (C2) functionalities are only slightly deshielded upon complexation. This was also observed for the Ag(I) complexes of the coumarin-3-carboxylates and it was reported that the noted small shifts may be as a result of hydrogen-bonding present in the free ligands in DMSO solution. The 1 H NMR spectra of the phenanthroline-containing complexes 4d, 4f and 4g has four additional signals at ca. 9.17, 8.77, 8.21, 8 .01 ppm corresponding to the protons of the phenanthroline ligands. The integrals confirm that the 2:1 phen:coumarin ratio for complexes 4d and 4g and the 1:1 phen:coumarin ratio for 4f. On comparison with the spectra of the free phenanthroline ligand, small downfield shifts for the three of protons were observed in the spectra of all the complexes, similar to those noted for the mixed ligand Ag(I) complex of 4-hydroxy-3-nitro-2H-chromen-2-one [25] . There are six signals observed in the 13 C NMR spectra of the complexes representing the non-equivalent carbons of the phenanthroline ligands all of which displayed relatively small CIS.
Molar conductivity
The molar conductivities of the Ag(I) complexes, 3a-l ( [45] . The molar conductivity of the mixed ligand complexes 4d, 4f and 4g was not recorded due to the poor solubility of the complexes in DMSO solvent.
Antimicrobial activity of coumarin ligands and their Ag(I) complexes
The Ag(I) complexes (3a-l, 4d, 4f, 4g), the free ligands and the metal salt AgNO 3 were screened for their activity against two Gram negative bacteria E. coli (NCIMB9485) and P. aeruginosa (ATCC 27853) and two strains of the Gram positive bacteria S. aureus, a methicillin sensitive strain, NCIMB12702 and a methicillin-resistant strain, ATCC4300 (MRSA). Commercial drugs vancomycin and gentamycin were also tested for their activities against relevant microbial strains. The antimicrobial activity of the compounds given in Table 10 and are expressed as MIC 90 values (minimum concentration required to inhibit 90% of visible cell growth in 24 h). Although a number of coumarin-derived compounds have previously shown antimicrobial activity [45] , none of the synthesised metal-free coumarin ligands or phenanthroline showed any inhibition of growth at the maximum concentrations tested.
The Ag(I) complexes showed some antibacterial activity particularly against E. coli and P. aeruginosa. The activity of the complexes 3a-f, 3i-l tested against E. coli were slightly less than that of silver nitrate (MIC 90 = 36.1 lM) and generally all were greater in activity than gentamycin (60.3 lM). The type of substituent present on the benzene ring did not seem to influence their activity significantly against E. coli however the activity of the complexes (3a-h) tested against the P. aeruginosa ATCC 27853 did vary depending on the type of substituent present on the benzene ring. Complexes with a methoxy substituent only (3a-c) had similar activity and were comparable to that of AgNO 3 (92.8 lM). complexes with halogen substituents (3d-h) were observed to have greater activity. Compounds with electron-withdrawing substituents such as halogens can have increased lipophilicity and hence an improved cell permeability of microorganisms. An increase in liposolubility is an important factor for antimicrobial activity and several groups have reported that the influence of a halogen substituent in a compound can affect its activity by steric or electronic effects [46] [47] [48] . The dichloro substituted complex [Ag (7, CA)] (3h) showed activity (MIC 90 = 90 lM) similar to the methoxy substituted complexes. The decrease in activity is likely as a result of its poor solubility and indeed meant that the complex had to be tested as a suspension. Six of the complexes (3a-f) were also tested against P. aeruginosa (PA01) either in planktonic form or as a biofilm (MIC 90 values given in Table 11 ). Overall the activity of the substituted complexes against the planktonic strain was comparable to that found against P. aeruginosa ATCC 27853. The sensitivity of different strains of the same organism to a single antibiotic can depend upon the morphological and physiological characteristics of the strains [49] but there was no significant variation noted here.
The activity of silver and its complexes, including silver sulfadiazine, against P. aeruginosa biofilms has been studied previously by Bjarnsholt et al. and they found that the bactericidal concentration of silver needed to eliminate the bacterial biofilm was between 10 and 100 times greater than that used to eliminate planktonic bacteria [50] . Complexes 3a-f and AgNO 3 were found to be more active against the biofilm form of PA01 than the planktonic form and all BIC values were comparable. The complexes were approximately 4-6 times more potent against the biofilm than the planktonic form. This is clinically important as bacteria living in a biofilm can be up to 1000 times more resistant to antimicrobial agents than planktonic bacteria [51] . The antibacterial mechanism of silver ions has been well studied and it is possible that in these studies the silver complexes act by disrupting the signal processes associated with biofilm formation as the mechanisms involved in biofilm resistance to antimicrobials may differ from those responsible for antimicrobial resistance in planktonic bacteria. Biofilm resistance is multifactorial and includes a diffusion barrier, sequestration of antibiotics within the glucan polymers, slower growth, reduced oxygen concentrations at the base of the biofilm [52, 53] . As such only a combination of different mechanisms could account for the levels of resistance seen in biofilm communities [54] . The fact that silver is said to have broad-spectrum activity in which it attacks multiple sites of microorganisms may be a factor in the enhanced activity shown by the silver complexes against P. aeruginosa biofilm.
The phenanthroline containing complexes, 4d, 4f and 4g and free phenanthroline were tested for their activity against MRSA (ATCC4300) and P. aeruginosa (ATCC 27853). Surprisingly their solubility in the solvent was poor and as such they were tested as suspensions. Metal-free phenanthroline has previously been reported to have significant activity against a number of microbes [55] however it was found to be inactive against the microbes used in this study (MIC 90 > 100 lM). There is often variation in sensitivity of different strains of the same species to antimicrobial agents. Introduction of phenanthroline as a second ligand to the Ag(I) complexes improved the activity of 4d and 4g against P. aeruginosa only. The increase in activity would suggest a synergistic effect of both ligands and the silver ion. The MIC 90 values for the compounds against MRSA were all greater than 100 lM and so the introduction of phenanthroline did not increase the activity of the compounds against these microbes.
The activity of the complexes may be due to a synergistic effect of both ligand and metal ion or it may be as a result of the Ag(I) ion only. Silver has the ability to bind to the metal binding sites in proteins (sulfhydryl groups) thereby inactivating enzymes and blocking the respiratory chain of microorganisms [56] . The antimicrobial activity of several Ag(I) complexes of oxygen donor ligands is independent of whether the ligand itself possesses antimicrobial activity and results from the weaker bonding property of the Ag-O bond and the ease of ligand replacement of the Ag(I) complexes with biological ligands such as those with O, N or S donor atoms. The ligands are likely acting as carriers for the Ag(I) ion and the magnitude of the antimicrobial properties of the complexes is related to the ease with which they participate in ligand exchange reactions [57] . The complexation of the coumarin-4-carboxylates to Ag(I) resulted in enhanced antibacterial activity particularly towards E. coli and P. aeruginosa. Gram negative bacteria are generally less sensitive to biocides than Gram positive bacteria because of their outer membrane or envelope. The outer cell layer of Gram negative bacteria consists of an outer membrane, a thin layer of peptidoglycan and a periplasmic space and an inner membrane [58] . One of the effects of the outer envelope is to form an impermeable barrier that protects the microorganism from toxic molecules such as biocides and antibiotics. It allows the slow penetration of hydrophobic molecules and this decrease in penetration is responsible for the resistance of Gram negative bacteria to certain antibiotics. Several biocides can destabilise and disorganise the outer membrane thus gaining entry to the bacterial cell. Antibiotic passage may also occur by passive or facilitated diffusion through water-filled channels. The uptake and penetration process of the biocide will be influenced by interactions with all structures it encounters. Therefore the penetration of a biocide or antibiotic may often be determined by its physical properties rather than its specific structure. An optimal hydrophilic-lipophilic balance will enable the best penetration across the outer membrane and a complex mix of portioning and passive diffusion processes is thus likely to determine the progress of a biocide across the Gram-negative outer envelope [59] . It is therefore likely that the coordination of Ag(I) to the coumarin-4-carboxylate ligands results in a biocide with suitable physical properties which are capable of penetration of the outer membrane. The process in which it gains access is likely to be through an optimal hydrophilic-lipophilic balance. The increased activity of those complexes which had a halogen substituent also demonstrates the importance of lipophilicity for the activity of the complexes.
Conclusion
A number of novel Ag(I) coumarin-carboxylate complexes have exhibited moderate antimicrobial activity towards E. coli and P. aeruginosa. Some of the complexes showed greater activity against E. coli than gentamycin and were comparable in activity or greater than AgNO 3 against P. aeruginosa grown planktonically or as a biofilm. Six of the complexes (3a-f) were approximately 4-6 times more potent against the biofilm compared to planktonic bacteria and introduction of phenanthroline as a second ligand to the Ag(I) complexes improved the activity of 4d and 4g against a strain of P. aeruginosa only. The poor solubility of the complexes would likely limit their use as potential oral drugs but they could be used in a number of therapeutic applications including coatings, medical devices, catheters, wound dressings, sutures etc. We have previously shown the potential of Ag(I) coumarin carboxylates for use as effective biocides in hygienic thin film coatings and the novel Ag(I) complexes in this study can now be investigated for use as additives for hygienic coatings.
